Robust Screening and Cascade Testing for Fragile X Expansions in a Large Multigenerational Family Identify Many Affected Individuals: An Experience in the Remote Area of Indonesia
DOI:
https://doi.org/10.6000/2292-2598.2020.08.01.2Keywords:
Dried blood spot testing, screening, fragile X syndrome.Abstract
Fragile X Syndrome (FXS) is the most common known inherited form of intellectual disability (ID), caused by a CGG repeat expansion of the FMR1 gene. The aimed of the study was to screen FMR1 mutation among the ID population followed by cascade testing in a remote area. A PCR-based method was used to screen FMR1 expanded alleles using dried blood spot cards in Flores Island, one of the very remote areas in East Indonesia. The screening included 130 males and 81 females from three schools of children with ID. The screening identified three individuals with expanded alleles including two full mutation males and one premutation male. No expanded allele was detected in females. A second blood sample for confirmatory diagnosis was done using Southern blot. Cascade testing in a remote area of Indonesia found a multigenerational family with a large number of cases with FXS. FXS screening of ID populations followed by cascade testing in positive FXS family in a remote area with challenging accessibility is recommended.
References
Fu Y-H, Kuhl DPA, Pizzuti A, Pieretti M, Sutcliffe JS, Richards S, et al. Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox. Cell 1991; 67(6): 1047-1058. https://doi.org/10.1016/0092-8674(91)90283-5 DOI: https://doi.org/10.1016/0092-8674(91)90283-5
Verkerk AJ, Pieretti M, Sutcliffe JS, Fu YH, Kuhl DP, Pizzuti A, et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 1991; 65(5): 905-914. https://doi.org/10.1016/0092-8674(91)90397-H DOI: https://doi.org/10.1016/0092-8674(91)90397-H
Maddalena A, Richards CS, McGinniss MJ, Brothman A, Desnick RJ, Grier RE, et al. Technical standards and guidelines for fragile X: the first of a series of disease-specific supplements to the Standards and Guidelines for Clinical Genetics Laboratories of the American College of Medical Genetics. Quality Assurance Subcommittee of the Laboratory Practice Committee. Genet Med 2001; 3(3): 200-205. https://doi.org/10.1097/00125817-200105000-00010 DOI: https://doi.org/10.1097/00125817-200105000-00010
Fernandez-Carvajal I, Walichiewicz P, Xiaosen X, Pan R, Hagerman PJ, Tassone F. Screening for expanded alleles of the FMR1 gene in blood spots from newborn males in a Spanish population. J Mol Diagn 2009; 11(4): 324-329. https://doi.org/10.2353/jmoldx.2009.080173 DOI: https://doi.org/10.2353/jmoldx.2009.080173
Eichler EE, Holden JJ, Popovich BW, Reiss AL, Snow K, Thibodeau SN, et al. Length of uninterrupted CGG repeats determines instability in the FMR1 gene. Nat Genet 1994; 8(1): 88-94. https://doi.org/10.1038/ng0994-88 DOI: https://doi.org/10.1038/ng0994-88
Yrigollen CM, Durbin-Johnson B, Gane L, Nelson DL, Hagerman R, Hagerman PJ, et al. AGG interruptions within the maternal FMR1 gene reduce the risk of offspring with fragile X syndrome. Genet Med 2012; 14(8): 729-736. https://doi.org/10.1038/gim.2012.34 DOI: https://doi.org/10.1038/gim.2012.34
Hagerman RJ, Hagerman PJ. Fragile X syndrome: diagnosis, treatment, and research. 3rd ed. Baltimore: Johns Hopkins University Press 2002; xii: p. 540.
Sherman SL. Premature ovarian failure in the fragile X syndrome. Am J Med Genet (Semin Med Genet) 2000; 97(3): 189-194. https://doi.org/10.1002/1096-8628(200023)97:3<189::AID-AJMG1036>3.0.CO;2-J DOI: https://doi.org/10.1002/1096-8628(200023)97:3<189::AID-AJMG1036>3.0.CO;2-J
Hagerman RJ, Leehey M, Heinrichs W, Tassone F, Wilson R, Hills J, et al. Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology 2001; 57: 127-130. https://doi.org/10.1212/WNL.57.1.127 DOI: https://doi.org/10.1212/WNL.57.1.127
Hunter JE, Rohr JK, Sherman SL. Co-occurring diagnoses among FMR1 premutation allele carriers. Clin Genet 2010; 77(4): 374-381. https://doi.org/10.1111/j.1399-0004.2009.01317.x DOI: https://doi.org/10.1111/j.1399-0004.2009.01317.x
Lachiewicz A, Dawson D, Spiridigliozzi G, Cuccaro M, Lachiewicz M, McConkie-Rosell A. Indicators of anxiety and depression in women with the fragile X premutation: assessment of a clinical sample. J Intellect Disabil Res 2010; 54(7): 597-610. https://doi.org/10.1111/j.1365-2788.2010.01290.x DOI: https://doi.org/10.1111/j.1365-2788.2010.01290.x
Winarni TI, Chonchaiya W, Sumekar TA, Ashwood P, Morales GM, Tassone F, et al. Immune-mediated disorders among women carriers of fragile X premutation alleles. Am J Med Genet Part A 2012; 158A(10): 2473-2481. https://doi.org/10.1002/ajmg.a.35569 DOI: https://doi.org/10.1002/ajmg.a.35569
Tassone F, Hagerman PJ, Hagerman RJ. Fragile x premutation. J Neurodev Disord 2014; 6(1): 22. https://doi.org/10.1186/1866-1955-6-22 DOI: https://doi.org/10.1186/1866-1955-6-22
Fernandez-Carvajal I, Lopez Posadas B, Pan R, Raske C, Hagerman PJ, Tassone F. Expansion of an FMR1 grey-zone allele to a full mutation in two generations. J Mol Diagn 2009; 11(4): 306-310. https://doi.org/10.2353/jmoldx.2009.080174
Song FJ, Barton P, Sleightholme V, Yao GL, Fry-Smith A. Screening for fragile X syndrome: a literature review and modelling study. Health Technol Assess 2003; 7(16): 1-106. https://doi.org/10.3310/hta7160 DOI: https://doi.org/10.3310/hta7160
Faradz SMH, Buckley M, Tang L-P, Leigh D, Holden JJA. Molecular screening for fragile X syndrome among Indonesian children with developmental disability. Am J Med Genet A 1999; 83(4): 350-351. https://doi.org/10.1002/(SICI)1096-8628(19990402)83:4<350::AID-AJMG26>3.0.CO;2-G DOI: https://doi.org/10.1002/(SICI)1096-8628(19990402)83:4<350::AID-AJMG26>3.3.CO;2-7
Mundhofir FEP, Winarni TI, Nillesen W, van Bon BWM, Schepens M, Ruiterkamp-Versteeg M, et al. Prevalence of fragile X syndrome in males and females in Indonesia. World Journal of Medical Genetics 2012; 2(3): 15. https://doi.org/10.5496/wjmg.v2.i3.15
Mundhofir FE, Winarni TI, Nillesen W, Bon BWV, Schepens M, Ruiterkamp-Versteeg M, et al. Prevalence of fragile X syndrome in males and females in Indonesia. World J Med Genet 2012; 2(3): 15-22. https://doi.org/10.5496/wjmg.v2.i3.15 DOI: https://doi.org/10.5496/wjmg.v2.i3.15
Winarni TI, Mundhofir FE, Faradz SM. A Cohort Study of Intellectual Disability Focusing on Fragile X Syndrome in Indonesia 2016; 2016: 7. https://doi.org/10.14710/jbtr.v2i1.536 DOI: https://doi.org/10.14710/jbtr.v2i1.536
Indonesian Central Bureau of Statistic. Population of Indonesia by province 1971, 1980, 1990, 1995, 2000, 2010. http: //www.bps.go.id; 2011.
Winarni TI, Utari A, Mundhofir FE, Tong T, Durbin-Johnson B, Faradz SM, et al. Identification of expanded alleles of the FMR1 gene among high-risk population in Indonesia by using blood spot screening. Genet Test Mol Biomarkers 2012; 16(3): 162-166. https://doi.org/10.1089/gtmb.2011.0089 DOI: https://doi.org/10.1089/gtmb.2011.0089
Tassone F, Pan R, Amiri K, Taylor AK, Hagerman PJ. A rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the fragile X (FMR1) gene in newborn and high-risk populations. J Mol Diagn 2008; 10(1): 43-49. https://doi.org/10.2353/jmoldx.2008.070073 DOI: https://doi.org/10.2353/jmoldx.2008.070073
Tassone F, Iong KP, Tong TH, Lo J, Gane LW, Berry-Kravis E, et al. FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States. Genome Med 2012; 4(12): 100. https://doi.org/10.1186/gm401 DOI: https://doi.org/10.1186/gm401
Yuhas J, Walichiewicz P, Pan R, Zhang W, Casillas EM, Hagerman RJ, et al. High-risk fragile x screening in Guatemala: use of a new blood spot polymerase chain reaction technique. Genet Test Mol Biomarkers 2009; 13(6): 855-859. https://doi.org/10.1089/gtmb.2009.0108 DOI: https://doi.org/10.1089/gtmb.2009.0108
Sorensen PL, Gane LW, Yarborough M, Hagerman RJ, Tassone F. Newborn screening and cascade testing for FMR1 mutations. Am J Med Genet A 2013; 161A(1): 59-69. https://doi.org/10.1002/ajmg.a.35680 DOI: https://doi.org/10.1002/ajmg.a.35680
Chen L, Hadd A, Sah S, Filipovic-Sadic S, Krosting J, Sekinger E, et al. An Information-Rich CGG Repeat Primed PCR That Detects the Full Range of Fragile X Expanded Alleles and Minimizes the Need for Southern Blot Analysis. The Journal of Molecular Diagnostics 2010; 12(5): 589-600. https://doi.org/10.2353/jmoldx.2010.090227 DOI: https://doi.org/10.2353/jmoldx.2010.090227
Filipovic-Sadic S, Sah S, Chen L, Krosting J, Sekinger E, Zhang W, et al. A novel FMR1 PCR method for the routine detection of low abundance expanded alleles and full mutations in fragile X syndrome. Clin Chem 2010; 56(3): 399-408. https://doi.org/10.1373/clinchem.2009.136101 DOI: https://doi.org/10.1373/clinchem.2009.136101
Fernandez-Carvajal I, Lopez Posadas B, Pan R, Raske C, Hagerman PJ, Tassone F. Expansion of an FMR1 Grey-Zone Allele to a Full Mutation in Two Generations. J Mol Diagn 2009; 11(4): 306-310. https://doi.org/10.2353/jmoldx.2009.080174 DOI: https://doi.org/10.2353/jmoldx.2009.080174
Hagerman RJ, Berry-Kravis E, Hazlett HC, Bailey DB, Jr., Moine H, Kooy RF, et al. Fragile X syndrome. Nat Rev Dis Primers 2017; 3: 17065. https://doi.org/10.1038/nrdp.2017.65 DOI: https://doi.org/10.1038/nrdp.2017.65
McConkie-Rosell A, Abrams L, Finucane B, Cronister A, Gane LW, Coffey SM, et al. Recommendations from multi-disciplinary focus groups on cascade testing and genetic counseling for fragile X-associated disorders. J Genet Couns 2007; 16(5): 593-606. https://doi.org/10.1007/s10897-007-9099-y DOI: https://doi.org/10.1007/s10897-007-9099-y
Finucane B, Abrams L, Cronister A, Archibald AD, Bennett RL, McConkie-Rosell A. Genetic counseling and testing for FMR1 gene mutations: practice guidelines of the national society of genetic counselors. J Genet Couns 2012; 21(6): 752-760. https://doi.org/10.1007/s10897-012-9524-8 DOI: https://doi.org/10.1007/s10897-012-9524-8
Farzin F, Perry H, Hessl D, Loesch D, Cohen J, Bacalman S, et al. Autism spectrum disorders and attention-deficit/ hyperactivity disorder in boys with the fragile X premutation. J Dev Behav Pediatr 2006; 27(2 Suppl): S137-144. https://doi.org/10.1097/00004703-200604002-00012 DOI: https://doi.org/10.1097/00004703-200604002-00012
Tassone F, Hagerman RJ, Taylor AK, Mills JB, Harris SW, Gane LW, et al. Clinical involvement and protein expression in individuals with the FMR1 premutation. Am J Med Genet 2000; 91(2): 144-152. https://doi.org/10.1002/(SICI)1096-8628(20000313)91:2<144::AID-AJMG14>3.0.CO;2-V DOI: https://doi.org/10.1002/(SICI)1096-8628(20000313)91:2<144::AID-AJMG14>3.0.CO;2-V
Hessl D, Wang JM, Schneider A, Koldewyn K, Le L, Iwahashi C, et al. Decreased fragile X mental retardation protein expression underlies amygdala dysfunction in carriers of the fragile X premutation. Biol Psychiatry 2011; 70(9): 859-865. https://doi.org/10.1016/j.biopsych.2011.05.033 DOI: https://doi.org/10.1016/j.biopsych.2011.05.033
Chonchaiya W, Au J, Schneider A, Hessl D, Harris SW, Laird M, et al. Increased prevalence of seizures in boys who were probands with the FMR1 premutation and co-morbid autism spectrum disorder. Hum Genet 2012; 131(4): 581-589. https://doi.org/10.1007/s00439-011-1106-6 DOI: https://doi.org/10.1007/s00439-011-1106-6
Chonchaiya W, Nguyen DV, Au J, Campos L, Berry-Kravis EM, Lohse K, et al. Clinical involvement in daughters of men with fragile X-associated tremor ataxia syndrome. Clin Genet 2010; 78(1): 39-46. https://doi.org/10.1111/j.1399-0004.2010.01448.x DOI: https://doi.org/10.1111/j.1399-0004.2010.01448.x
Clifford S, Dissanayake C, Bui QM, Huggins R, Taylor AK, Loesch DZ. Autism spectrum phenotype in males and females with fragile X full mutation and premutation. J Autism Dev Disord 2007; 37(4): 738-747. https://doi.org/10.1007/s10803-006-0205-z DOI: https://doi.org/10.1007/s10803-006-0205-z
Hamlin AA, Sukharev D, Campos L, Mu Y, Tassone F, Hessl D, et al. Hypertension in FMR1 premutation males with and without fragile X-associated tremor/ataxia syndrome (FXTAS). Am J Med Genet Part A 2012; 158A(6): 1304-1309. https://doi.org/10.1002/ajmg.a.35323 DOI: https://doi.org/10.1002/ajmg.a.35323
Leehey MA, Legg W, Tassone F, Hagerman R. Fibromyalgia in fragile X mental retardation 1 gene premutation carriers. Rheumatology 2011; 50(12): 2233-2236. https://doi.org/10.1093/rheumatology/ker273 DOI: https://doi.org/10.1093/rheumatology/ker273
Roberts JE, Bailey DB, Jr., Mankowski J, Ford A, Sideris J, Weisenfeld LA, et al. Mood and anxiety disorders in females with the FMR1 premutation. Am J Med Genet B Neuropsychiatr Genet 2009; 150B(1): 130-139. https://doi.org/10.1002/ajmg.b.30786 DOI: https://doi.org/10.1002/ajmg.b.30786
Basuta K, Narcisa V, Chavez A, Kumar M, Gane L, Hagerman R, et al. Clinical phenotypes of a juvenile sibling pair carrying the fragile X premutation. Am J Med Genet A 2011; 155A(3): 519-525. https://doi.org/10.1002/ajmg.a.33446 DOI: https://doi.org/10.1002/ajmg.a.33446
Aziz M, Stathopulu E, Callias M, Taylor C, Turk J, Oostra B, et al. Clinical features of boys with fragile X premutations and intermediate alleles. Am J Med Genet 2003; 121B(1): 119-127. https://doi.org/10.1002/ajmg.b.20030 DOI: https://doi.org/10.1002/ajmg.b.20030
Goodlin-Jones B, Tassone F, Gane LW, Hagerman RJ. Autistic spectrum disorder and the fragile X premutation. J Dev Behav Pediatr 2004; 25(6): 392-398. https://doi.org/10.1097/00004703-200412000-00002 DOI: https://doi.org/10.1097/00004703-200412000-00002
Cornish K, Kogan C, Turk J, Manly T, James N, Mills A, et al. The emerging fragile X premutation phenotype: evidence from the domain of social cognition. Brain Cogn 2005; 57(1): 53-60. https://doi.org/10.1016/j.bandc.2004.08.020 DOI: https://doi.org/10.1016/j.bandc.2004.08.020
Moore CJ, Daly EM, Schmitz N, Tassone F, Tysoe C, Hagerman RJ, et al. A neuropsychological investigation of male premutation carriers of fragile X syndrome. Neuropsychologia 2004; 42(14): 1934-1947. https://doi.org/10.1016/j.neuropsychologia.2004.05.002 DOI: https://doi.org/10.1016/j.neuropsychologia.2004.05.002
Bailey DB, Jr., Raspa M, Olmsted M, Holiday DB. Co-occurring conditions associated with FMR1 gene variations: findings from a national parent survey. Am J Med Genet A 2008; 146A(16): 2060-2069. https://doi.org/10.1002/ajmg.a.32439 DOI: https://doi.org/10.1002/ajmg.a.32439
Hagerman R, Hoem G, Hagerman P. Fragile X and autism: Intertwined at the molecular level leading to targeted treatments. Mol Autism 2010; 1(1): 12. https://doi.org/10.1186/2040-2392-1-12 DOI: https://doi.org/10.1186/2040-2392-1-12
Garcia-Arocena D, Hagerman PJ. Advances in understanding the molecular basis of FXTAS. Hum Mol Genet 2010; 19(R1): R83-89. https://doi.org/10.1093/hmg/ddq166 DOI: https://doi.org/10.1093/hmg/ddq166
Tassone F, Hagerman RJ, Taylor AK, Gane LW, Godfrey TE, Hagerman PJ. Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome. Am J Hum Genet 2000; 66(1): 6-15. https://doi.org/10.1086/302720 DOI: https://doi.org/10.1086/302720
Lozano R, Hagerman RJ, Duyzend M, Budimirovic DB, Eichler EE, Tassone F. Genomic studies in fragile X premutation carriers. J Neurodev Disord 2014; 6(1): 27. https://doi.org/10.1186/1866-1955-6-27 DOI: https://doi.org/10.1186/1866-1955-6-27
Myers GF, Mazzocco MM, Maddalena A, Reiss AL. No widespread psychological effect of the fragile X premutation in childhood: evidence from a preliminary controlled study. J Dev Behav Pediatr 2001; 22(6): 353-359. https://doi.org/10.1097/00004703-200112000-00001 DOI: https://doi.org/10.1097/00004703-200112000-00001
Downloads
Published
How to Cite
Issue
Section
